nach oben

Erschienen in:

26.06.2019 | Ernährung | Integrative Onkologie

Sarkopenie − Diagnostik und mögliche Therapien

verfasst von: Cand. Dr Med. Lian Liu, Nicole Tonya Erickson, M.Sc., RD, Cand. Sc. Gesundheitswissenschaften Laura-Sophie Marquort, Dr. Thorsten Schmidt, Dipl. Oec. Troph. Christine Reudelstertz, Dr. med. Julian W. Holch

Erschienen in: Die Onkologie | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Sarkopenie bedeutet Verlust von Muskelmasse und -funktion. Die derzeitige Forschung zum Begriff der Sarkopenie fokussiert sich größtenteils auf geriatrische Patienten und zeigt deutlich, dass Sarkopenie die Fähigkeit der Alltagsbewältigung erheblich einschränkt, zu Bewegungsstörungen führen und die Lebensqualität mindern kann. Bei Tumorpatienten geht das Vorhandensein von Sarkopenie mit einer erhöhten Morbidität und Mortalität einher. Auch wenn sich das Verständnis für das Krankheitsbild und die Behandlung von Sarkopenie bereits gebessert hat, konnten Forschungsergebnisse bisher noch nicht in den klinischen Alltag integriert werden. Deshalb fasst dieser Artikel die aktualisierte Definition von Sarkopenie zusammen und bietet einen Einblick in die Therapiemethoden. Des Weiteren wird die Bedeutung Evidenz unterstützender Ernährungsinterventionen und Bewegung für die Therapie von Sarkopenie erläutert.

Die Terminologie Muskelproteinsynthese und myofibrilläre Proteinsynthese werden austauschbar angewendet. Sie werden aber mit den gleichen Formeln berechnet.

Bozzetti F (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol 28(9):2107–2118. https://doi.org/10.1093/annonc/mdx271 CrossRefPubMed

Lin JX, Lin JP, Xie JW, Wang JB, Lu J, Chen QY et al (2019) Prognostic value and association of sarcopenia and systemic inflammation for patients with gastric cancer following radical gastrectomy. Oncologist. https://doi.org/10.1634/theoncologist.2018-0651 CrossRefPubMedPubMedCentral

Batsis JA, Mackenzie TA, Jones JD, Lopez-Jimenez F, Bartels SJ (2016) Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 National Health and Nutrition Examination Survey. Clin Nutr 35(6):1472–1483. https://doi.org/10.1016/j.clnu.2016.03.028 CrossRefPubMedPubMedCentral

Morishita S (2016) Prevalence of Sarcopenia in cancer patients: review and future directions. Int J Phys Med Rehabil 4:342

Cespedes Feliciano EM, Lee VS, Prado CM, Meyerhardt JA, Alexeeff S, Kroenke CH et al (2017) Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C‑SCANS study. Cancer 123(24):4868–4877. https://doi.org/10.1002/cncr.30950 CrossRefPubMed

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169 CrossRefPubMed

Goisser S, Kob R, Sieber CC, Bauer JM (2019) Diagnosis and therapy of sarcopenia-an update. Internist 60(2):141–148. https://doi.org/10.1007/s00108-018-0551-x CrossRef

Gonzalez MC, Correia M, Heymsfield SB (2017) A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care 20(5):314–321. https://doi.org/10.1097/mco.0000000000000395 CrossRefPubMed

Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31(12):1539–1547. https://doi.org/10.1200/jco.2012.45.2722 CrossRefPubMed

10.

Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C et al (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33(1):90–99. https://doi.org/10.1200/jco.2014.56.1894 CrossRefPubMed

11.

Gonzalez MC, Heymsfield SB (2017) Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle 8(2):187–189. https://doi.org/10.1002/jcsm.12159 CrossRefPubMedPubMedCentral

12.

Reiss J, Iglseder B, Kreutzer M, Weilbuchner I, Treschnitzer W, Kassmann H et al (2016) Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X‑ray absorptiometry. BMC Geriatr 16:52. https://doi.org/10.1186/s12877-016-0228-z CrossRefPubMedPubMedCentral

13.

Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA et al (2016) Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol 34(12):1339–1344. https://doi.org/10.1200/jco.2015.63.6043 CrossRefPubMed

14.

Cespedes Feliciano EM, Avrutin E, Caan BJ, Boroian A, Mourtzakis M (2018) Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality. J Cachexia Sarcopenia Muscle 9(5):898–908. https://doi.org/10.1002/jcsm.12317 CrossRefPubMedPubMedCentral

15.

Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635. https://doi.org/10.1016/s1470-2045(08)70153-0 CrossRefPubMed

16.

Prado CM, Maia YL, Ormsbee M, Sawyer MB, Baracos VE (2013) Assessment of nutritional status in cancer—the relationship between body composition and pharmacokinetics. Anticancer Agents Med Chem 13(8):1197–1203CrossRefPubMed

17.

Dolan RD, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC (2019) The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle 10(1):111–122. https://doi.org/10.1002/jcsm.12357 CrossRefPubMed

18.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T et al (2019) Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery 165(2):329–336. https://doi.org/10.1016/j.surg.2018.07.031 CrossRefPubMed

19.

Peterson SJ, Mozer M (2017) Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract 32(1):30–39. https://doi.org/10.1177/0884533616680354 CrossRefPubMed

20.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015 CrossRefPubMed

21.

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP et al (2017) ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 36(5):1187–1196. https://doi.org/10.1016/j.clnu.2017.06.017 CrossRefPubMed

22.

Kim H, Yoo S, Park YS, Park SG (2018) Low dietary energy intake is associated with sarcopenia in cancer survivors: an analysis based on the Korean national health and nutrition examination survey 2008–2011. Nutr Res 53:15–22. https://doi.org/10.1016/j.nutres.2018.01.004 CrossRefPubMed

23.

Baracos VE, Mazurak VC, Bhullar AS (2019) Cancer cachexia is defined by an ongoing loss of skeletal muscle mass. Ann Palliat Med 8(1):3–12. https://doi.org/10.21037/apm.2018.12.01 CrossRefPubMed

24.

Tessier AJ, Chevalier S (2018) An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients. https://doi.org/10.3390/nu10081099 CrossRefPubMedPubMedCentral

25.

Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29(1):43–48. https://doi.org/10.1007/s40520-016-0709-0 CrossRefPubMed

26.

Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G et al (2008) Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 12(7):433–450CrossRefPubMedPubMedCentral

27.

Fujita S, Volpi E (2006) Amino acids and muscle loss with aging. J Nutr 136(1 Suppl):277s–280s. https://doi.org/10.1093/jn/136.1.277S CrossRefPubMed

28.

Timmerman KL, Volpi E (2008) Amino acid metabolism and regulatory effects in aging. Curr Opin Clin Nutr Metab Care 11(1):45–49. https://doi.org/10.1097/MCO.0b013e3282f2a592 CrossRefPubMedPubMedCentral

29.

Morais JA, Chevalier S, Gougeon R (2006) Protein turnover and requirements in the healthy and frail elderly. J Nutr Health Aging 10(4):272–283PubMed

30.

Huang RY, Yang KC, Chang HH, Lee LT, Lu CW, Huang KC (2016) The association between total protein and vegetable protein intake and low muscle mass among the community-dwelling elderly population in northern Taiwan. Nutrients. https://doi.org/10.3390/nu8060373 CrossRefPubMedPubMedCentral

31.

Groen BB, Res PT, Pennings B, Hertle E, Senden JM, Saris WH et al (2012) Intragastric protein administration stimulates overnight muscle protein synthesis in elderly men. Am J Physiol Endocrinol Metab 302(1):E52–E60. https://doi.org/10.1152/ajpendo.00321.2011 CrossRefPubMed

32.

Welle S, Thornton CA (1998) High-protein meals do not enhance myofibrillar synthesis after resistance exercise in 62- to 75-yr-old men and women. Am J Physiol 274(4):E677–E683. https://doi.org/10.1152/ajpendo.1998.274.4.E677 CrossRefPubMed

33.

Dirks ML, Wall BT, Nilwik R, Weerts DH, Verdijk LB, van Loon LJ (2014) Skeletal muscle disuse atrophy is not attenuated by dietary protein supplementation in healthy older men. J Nutr 144(8):1196–1203. https://doi.org/10.3945/jn.114.194217 CrossRefPubMed

34.

Coelho-Junior HJ, Milano-Teixeira L, Rodrigues B, Bacurau R, Marzetti E, Uchida M (2018) Relative protein intake and physical function in older adults: a systematic review and Meta-analysis of observational studies. Nutrients. https://doi.org/10.3390/nu10091330 CrossRefPubMedPubMedCentral

35.

Paddon-Jones D, Rasmussen BB (2009) Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 12(1):86–90. https://doi.org/10.1097/MCO.0b013e32831cef8b CrossRefPubMedPubMedCentral

36.

English KL, Mettler JA, Ellison JB, Mamerow MM, Arentson-Lantz E, Pattarini JM et al (2016) Leucine partially protects muscle mass and function during bed rest in middle-aged adults. Am J Clin Nutr 103(2):465–473. https://doi.org/10.3945/ajcn.115.112359 CrossRefPubMed

37.

Dickinson JM, Gundermann DM, Walker DK, Reidy PT, Borack MS, Drummond MJ et al (2014) Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men. J Nutr 144(11):1694–1702. https://doi.org/10.3945/jn.114.198671 CrossRefPubMedPubMedCentral

38.

Kim HK, Suzuki T, Saito K, Yoshida H, Kobayashi H, Kato H et al (2012) Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc 60(1):16–23. https://doi.org/10.1111/j.1532-5415.2011.03776.x CrossRefPubMed

39.

Deutz NE, Safar A, Schutzler S, Memelink R, Ferrando A, Spencer H et al (2011) Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin Nutr 30(6):759–768. https://doi.org/10.1016/j.clnu.2011.05.008 CrossRefPubMedPubMedCentral

40.

Cholewa JM, Dardevet D, Lima-Soares F, de Araujo Pessoa K, Oliveira PH, Dos Pinho SJR et al (2017) Dietary proteins and amino acids in the control of the muscle mass during immobilization and aging: role of the MPS response. Amino Acids 49(5):811–820. https://doi.org/10.1007/s00726-017-2390-9 CrossRefPubMed

41.

Engelen MP, Safar AM, Bartter T, Koeman F, Deutz NE (2015) High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer. Ann Oncol 26(9):1960–1966. https://doi.org/10.1093/annonc/mdv271 CrossRefPubMedPubMedCentral

42.

Ceglia L, Harris SS (2013) Vitamin D and its role in skeletal muscle. Calcif Tissue Int 92(2):151–162. https://doi.org/10.1007/s00223-012-9645-y CrossRefPubMed

43.

Ceglia L (2009) Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12(6):628–633. https://doi.org/10.1097/MCO.0b013e328331c707 CrossRefPubMedPubMedCentral

44.

Wimalawansa SJ (2018) Non-musculoskeletal benefits of vitamin D. J Steroid Biochem Mol Biol 175:60–81. https://doi.org/10.1016/j.jsbmb.2016.09.016 CrossRefPubMed

45.

Boersma D, Demontiero O, Mohtasham Amiri Z, Hassan S, Suarez H, Geisinger D et al (2012) Vitamin D status in relation to postural stability in the elderly. J Nutr Health Aging 16(3):270–275CrossRefPubMed

46.

Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O (2009) Vitamin D‑related changes in physical performance: a systematic review. J Nutr Health Aging 13(10):893–898CrossRefPubMed

47.

Dupuy C, Lauwers-Cances V, van Kan GA, Gillette S, Schott AM, Beauchet O et al (2013) Dietary vitamin D intake and muscle mass in older women. Results from a cross-sectional analysis of the EPIDOS study. J Nutr Health Aging 17(2):119–124. https://doi.org/10.1007/s12603-012-0089-x CrossRefPubMed

48.

Wang J, Wang X, Gu Y, Liu M, Chi VTQ, Zhang Q et al (2019) Vitamin D is related to handgrip strength in adult men aged 50 years and over: a population study from the TCLSIH cohort study. Clin Endocrinol (Oxf) 90(5):753–765. https://doi.org/10.1111/cen.13952 CrossRef

49.

Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I et al (2018) Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr 37(4):1121–1132. https://doi.org/10.1016/j.clnu.2017.08.016 CrossRefPubMed

50.

Holch JW, Michl M, Heinemann V, Erickson N (2017) Vitamine und Spurenelemente in der Onkologie. Dtsch Med Wochenschr 142(12):896–902. https://doi.org/10.1055/s-0042-112046 CrossRefPubMed

51.

Rondanelli M, Faliva M, Monteferrario F, Peroni G, Repaci E, Allieri F et al (2015) Novel insights on nutrient management of sarcopenia in elderly. Biomed Res Int 2015:524948. https://doi.org/10.1155/2015/524948 CrossRefPubMedPubMedCentral

52.

Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ et al (2011) Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 93(2):402–412. https://doi.org/10.3945/ajcn.110.005611 CrossRefPubMed

53.

Cornish SM, Chilibeck PD (2009) Alpha-linolenic acid supplementation and resistance training in older adults. Applied physiology, nutrition, and metabolism. Appl Physiol Nutr Metab 34(1):49–59. https://doi.org/10.1139/h08-136 CrossRefPubMed

54.

Logan SL, Spriet LL (2015) Omega-3 fatty acid supplementation for 12 weeks increases resting and exercise metabolic rate in healthy community-dwelling older females. PLoS ONE 10(12):e144828. https://doi.org/10.1371/journal.pone.0144828 CrossRefPubMedPubMedCentral

55.

Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ et al (2003) Effect of a protein and energy dense N‑3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479–1486. https://doi.org/10.1136/gut.52.10.1479 CrossRefPubMedPubMedCentral

56.

Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G et al (2003) Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21(1):129–134. https://doi.org/10.1200/jco.2003.01.101 CrossRefPubMed

57.

Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G (2014) Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care 17(2):145–150. https://doi.org/10.1097/mco.0000000000000032 CrossRefPubMed

58.

Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008465.pub2 CrossRefPubMedPubMedCentral

59.

Liedtke S, Schmidt ME, Becker S, Kaaks R, Zaineddin AK, Buck K et al (2011) Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? Cancer Causes Control 22(1):81–89. https://doi.org/10.1007/s10552-010-9677-4 CrossRefPubMed

60.

Fortunati N, Catalano MG, Boccuzzi G, Frairia R (2010) Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol 316(1):86–92. https://doi.org/10.1016/j.mce.2009.09.012 CrossRefPubMed

61.

Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS (2016) Physical activity and survival after prostate cancer. Eur Urol 70(4):576–585. https://doi.org/10.1016/j.eururo.2015.12.032 CrossRefPubMed

62.

Duregon F, Vendramin B, Bullo V, Gobbo S, Cugusi L, Di Blasio A et al (2018) Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. Crit Rev Oncol Hematol 121:90–100. https://doi.org/10.1016/j.critrevonc.2017.11.002 CrossRefPubMed

63.

Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G et al (2014) Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol 25(2):493–499. https://doi.org/10.1093/annonc/mdt568 CrossRefPubMed

64.

Vollmers PL, Mundhenke C, Maass N, Bauerschlag D, Kratzenstein S, Rocken C et al (2018) Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy. J Cancer Res Clin Oncol 144(9):1785–1792. https://doi.org/10.1007/s00432-018-2686-5 CrossRefPubMed

65.

Schmidt T, Berner J, Jonat W, Weisser B, Rocken C, van Mackelenbergh M et al (2017) Influence of arm crank ergometry on development of lymphedema in breast cancer patients after axillary dissection: a randomized controlled trail. J Rehabil Med 49(1):78–83. https://doi.org/10.2340/16501977-2167 CrossRefPubMed

66.

Sheffield-Moore M, Yeckel CW, Volpi E, Wolf SE, Morio B, Chinkes DL et al (2004) Postexercise protein metabolism in older and younger men following moderate-intensity aerobic exercise. Am J Physiol Endocrinol Metab 287(3):E513–E522. https://doi.org/10.1152/ajpendo.00334.2003 CrossRefPubMed

67.

Charifi N, Kadi F, Feasson L, Denis C (2003) Effects of endurance training on satellite cell frequency in skeletal muscle of old men. Muscle Nerve 28(1):87–92. https://doi.org/10.1002/mus.10394 CrossRefPubMed

68.

Lonbro S (2014) The effect of progressive resistance training on lean body mass in post-treatment cancer patients—a systematic review. Radiother Oncol 110(1):71–80. https://doi.org/10.1016/j.radonc.2013.07.008 CrossRefPubMed

69.

Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K (2015) Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. Int J Cancer 137(2):471–480. https://doi.org/10.1002/ijc.29383 CrossRefPubMed

70.

Schmidt T, Weisser B, Durkop J, Jonat W, Van Mackelenbergh M, Rocken C et al (2015) Comparing endurance and resistance training with standard care during chemotherapy for patients with primary breast cancer. Anticancer Res 35(10):5623–5629PubMed

71.

Stubblefield MD, Burstein HJ, Burton AW, Custodio CM, Deng GE, Ho M et al (2009) NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw 7(Suppl 5):S1–S26 (quiz S7–8)CrossRefPubMed

72.

Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759. https://doi.org/10.1093/ageing/afu115 CrossRefPubMedPubMedCentral

Titel: Sarkopenie − Diagnostik und mögliche Therapien
verfasst von: Cand. Dr Med. Lian Liu
Nicole Tonya Erickson, M.Sc., RD
Cand. Sc. Gesundheitswissenschaften Laura-Sophie Marquort
Dr. Thorsten Schmidt
Dipl. Oec. Troph. Christine Reudelstertz
Dr. med. Julian W. Holch
Publikationsdatum: 26.06.2019
Verlag: Springer Medizin
Schlagwörter: Ernährung
Sarkopenie
Erschienen in: Die Onkologie / Ausgabe 9/2019
Print ISSN: 2731-7226
Elektronische ISSN: 2731-7234
DOI: https://doi.org/10.1007/s00761-019-0614-1

Passend zum Thema

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Ernährung

Müdigkeit und Erschöpfung sind meist die ersten Symptome eines Vitamin-B12-Mangels. Wird das Defizit nicht rechtzeitig behandelt, drohen mitunter schwerwiegende Folgen. Lesen Sie hier, was bei der Therapie zu beachten ist.

Vitamin-B12-Mangel durch Arzneimittel

Ernährung

Einige häufig verordnete Medikamente wie das orale Antidiabetikum Metformin oder Protonenpumpeninhibitoren (PPI) können einen Mangel an Vitamin B12 verursachen. Bei einer Langzeitmedikation mit diesen Wirkstoffen sollte daher an ein mögliches Defizit gedacht werden. Erfahren Sie hier, worauf dabei zu achten ist.

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.

Content Hub

Ein Mangel an Vitamin B12 tritt in bestimmten Risikogruppen häufig auf. Diese Patienten sind auch regelmäßig in Ihrer Praxis. Wird der Mangel nicht rechtzeitig behandelt, drohen mitunter schwerwiegende Folgen. Erhalten Sie hier einen Überblick über aktuelles Basiswissen für den Praxisalltag.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

CME: Plattenepithelkarzinom der Haut

Besonderheiten der onkologischen Chirurgie beim alten Patienten

Kolorektales Karzinom: MSI-Analyse sollte zum Standard gehören

Lokal-ablative Radiotherapie des oligometastasierten Prostatakarzinoms mit Überlebensvorteil

Die Vorteile des geriatrischen Screenings in der Onkologie

„Für mich ein Fremdwort, das ich bisher nicht gehört habe“ – Was Krebspatienten unter dem Begriff psychosoziale Unterstützung verstehen

Passend zum Thema

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Vitamin-B12-Mangel durch Arzneimittel

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.